Characterization of polymorphisms in the mannose-binding lectin gene promoter among human immunodeficiency virus 1 infected subjects

Memorias do Instituto Oswaldo Cruz

Volumn 103, Issue 7, 2008, Pages 645-649

  Vallinoto, A C R ^a   Muto, N A ^a   Alves, A E M ^a   Machado, L F A ^a   Azevedo, V N ^a   Souza, L L B ^b   Ishak, M O G ^a   Ishak, R ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b Unidade de Referencia Especializada em Doencas Infecciosas e Parasitarias Especiais   (Brazil)

Author keywords

Genetic polymorphism; Human immunodeficiency virus; Mannose binding lectin

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

MANNOSE BINDING LECTIN;

ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; DISEASE COURSE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; SERODIAGNOSIS; VIROLOGY; VIRUS LOAD;

CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; MANNOSE-BINDING LECTIN; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; VIRAL LOAD;

EID: 56749105386     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762008000700003     Document Type: Article

References (23)

1. Ayres M, Ayres Jr M, Ayres DL, Santos AS 2005. BioEstat 4.0: Aplicações estatísticas nas áreas das ciências biológicas e médicas. Sociedade Civil Mamirauá/MCT- CNPq/Corservation International, Belém, 323 pp.
2. Cohen OJ, Kinter A, Fauci AS 1997. Host factors in the pathogenesis of HIV disease. Immunol Rev 159: 31-48.
3. Garred P, Madsen HO, Balslev U, Hofmann B, Pedersen C, Gerstoft J, Svejgaard A 1997a. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose binding lectin. Lancet 349: 236-240.
4. Garred P, Richter C, Andersen AB, Madsen HO, Mtoni I, Svejgaard A, Shao J 1997b. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics. Scand J Immunol 46: 204-208.
5. Hakozaki Y, Yoshiba M, Sekiyama K 2002. Manose-binding lectin and the prognosis of fulminate hepatic failure caused by HBV infection. Liver 35: 29-34.
6. Kilpatrick DC 2002. Mannan-binding lectin and its role in innate immunity. Transfus Med 12: 335-351.
7. Korber B, Muldoon M, Theiler J, Gao F, Gupta R, Lapedes A, Hahn BH, Wolinsky S, Bhattacharya T 2000. Timing the ancestor of the HIV-1 pandemic strain. Science 288: 1789-1796.
8. Maas J, Husman AMR, Brouwer M, Krol A, Coutinho R, Keet I, Van Leeuwen R, Schuittemaker H 1998. Presence of the variant mannose-binding lectin alleles associated with slower progression to AIDS. Amsterdam Cohort Study. AIDS 12: 2275-2280.
9. Madsen HO, Garred P, Kurtzhals JA, Lamm LU, Ryder LP, Thiel S, Svejgaard A 1994. A new frequent allele is the missing link in the structural polymorphism of the human mannan-binding protein. Immunogen 40: 37-44.
10. Madsen HO, Garred P, Thiel S, Kurtzhals JAL, Lamm LU, Ryder LP, Svejgaard A 1995. Interplay between promoter and structural gene variants control basal serum level of mannan-biding protein. J Immunol 155: 3013-3020.
11. Mangano A, Rocco C, Marino SM, Mecikovsky D, Genre F, Aulicino P, Bologna R, Sen L 2008. Detrimental effects of mannose-binding lectin (MBL2) promoter genotype XA/XA on HIV-1 vertical transmission and AIDS progression. J Infect Dis 198: 694-700.
12. Mcbride MO, Fischer PB, Sumiya M, Mcclure MO, Turner MW, Skinner CJ, Weber JN, Summerfield JA 1998. Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections. Int J STD AIDS 9: 683-688.
13. Michington RM, Dean MM, Clark TR, Healey S, Mullighan 2002. Analysis of relationship between mannose-binding lectin (MBL) genotype, MBL levels and function in an Australian blood donor population. J Immunol 56: 630-641.
14. Miller MP 1999. Tools for population genetic analyses (TFPGA) 1.3v. A windows program for the analysis of allozyme and molecular population genetic data. Department of Biological Sciences, Nothern Arizona University, Flagstaff, 30 pp.
15. MS - Ministério da Saúde 2004. Recomendaçõ es para terapia antiretroviral em adultos e adolescentes infectados pelo HIV. Secretaria de Vigilância em Saúde, Programa Nacional de DST e Aids, Brasília, 140 pp.
16. Nielsen SL, Andersen PL, Koch C, Jensenius JC, Thiel 1995. The level of the serum opsonin, mannan-binding protein in HIV-1 antibody-positive patients. Clin and Exp Immunol 100: 219-222.
17. Pastinen T, Liitsola K, Niini P, Alminen M, Syvänen AC 1998. Contribution of the CCR5 and MBL genes susceptibility to HIV type I infection in the Finnish population. AIDS Res Hum Retrovir 14: 171-175.
18. Prohaszka Z, Thiel S, Ujhelyi E, Szlavik J, Banhegyi D, Fust G 1997. Mannan-binding lectin serum concentrations in HIV-infected patients are influenced by the stage of disease. Immunol Lett 58: 171-175.
19. Senaldi G, Davies ET, Mahalingam M, Lu J, Pozniak A, Peakman M, Reid KB, Vergani D 1999. Circulating levels of mannose binding protein in human immunodeficiency virus infection. J Infect 31: 145-148.
20. Steffensen R, Thiel S, Varming K, Jersild C, Jensenius JC 2000. Detection of structural gene mutations and promoter polymorphisms in the mannan-binding lectin (MBL) gene by polymerase chain reaction with sequence-specific primers. J Immun Methods 241: 33-42.
21. Turner MW 2003. The role of mannose-binding lectin in health and disease. Mol Immnunol 40: 423-429.
22. Vallinoto AC, Menezes-Costa MR, Alves AE, Machado LF, Azevedo VN, Souza LL, Ishak MOG, Ishak R 2006. Mannose-binding lectin gene polymorphism and its impact on human immunodeficiency virus 1 infection. Mol Immunol 43: 1358-1362.
23. Wong NK, Kojima M, Dobo J, Ambrus G, Sim RB 1999. Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors. Mol Immunol 36: 853-861.